Cancer

News

Deep Lens unveils cancer diagnosis AI tech for pathologists

Digital pathology startup Deep Lens has unveiled an artificial intelligence (AI) platform that will enable pathologists to diagnose cancer patients more swiftly and accurately.

News

BMS Opdivo fails in small cell lung cancer

Bristol-Myers Squibb has said its Opdivo immunotherapy has failed to improve on standard of care in patients with small cell lung cancer, who had relapsed following platinum-based chemother

News

BMS invests $12m in cancer immunotherapy tie-up with Compuge...

Bristol-Myers Squibb has invested $12 million in Compugen, a biotech that is investigating a new approach that could boost the effectiveness of its blockbuster cancer immunotherapy Opdivo.<

News

Celltrion/Teva Rituxan biosimilar edges closer to US approva...

It looks increasingly likely that Roche’s cancer blockbuster Rituxan (rituximab) will face competition from a cheaper biosimilar in the coming months after backing from an FDA expert commit

News

NHS to reimburse Gilead's CAR-T in adults

The first CAR-T therapy aimed at adults with lymphoma is to be reimbursed in England after manufacturer Gilead struck a deal with NHS.

News

Lilly's breast cancer drug Verzenio approved in EU

Eli Lilly’s Verzenio breast cancer drug has been approved in Europe, as the pharma prepares to compete with established rivals from Pfizer and Novartis.

Deep Lens unveils cancer diagnosis AI tech for pathologists

BMS Opdivo fails in small cell lung cancer

BMS invests $12m in cancer immunotherapy tie-up with Compuge...

Celltrion/Teva Rituxan biosimilar edges closer to US approva...

NHS to reimburse Gilead's CAR-T in adults

Lilly's breast cancer drug Verzenio approved in EU

Delivering the right behavioural ingredients for the moment,...

How to meet your physicians where they are online

Cancer

Editor's Picks